Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta
Alt, A., Lammens, K., Chiocchini, C., Lammens, A., Pieck, J.C., Kuch, D., Hopfner, K.P., Carell, T.(2007) Science 318: 967-970
- PubMed: 17991862 
- DOI: 10.1126/science.1148242
- Primary Citation of Related Structures:  
2R8J, 2R8K - PubMed Abstract: 
DNA polymerase eta (Pol eta) is a eukaryotic lesion bypass polymerase that helps organisms to survive exposure to ultraviolet (UV) radiation, and tumor cells to gain resistance against cisplatin-based chemotherapy. It allows cells to replicate across cross-link lesions such as 1,2-d(GpG) cisplatin adducts (Pt-GG) and UV-induced cis-syn thymine dimers ...